BPDCN is an aggressive type of blood cancer that originates from plasmacytoid dendritic cells (pDCs), a component ... but around 80% of cases involve the skin, according to the Leukemia and ...

An expert discusses how effective blastic plasmacytoid dendritic cell neoplasm (BPDCN) management requires early central nervous system (CNS) evaluation and a multidisciplinary approach, with ...

Food allergies are slowly increasing within first world countries. According to the National Institute of Allergy and Infectious Diseases (NIAID), 8% of ch | Immunology ...

Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor ...

An expert discusses how treatment selection in blastic plasmacytoid dendritic cell neoplasm (BPDCN) involves balancing disease-specific targeting and patient fitness, with tagraxofusp remaining the ...

New hope: MHH researchers are mobilising the immune system's defence against tumour cells within just two weeks using a two-phase vaccination regimen.

A new study from researchers at Moffitt Cancer Center shows that blocking a chemical process called nitrosylation could make ...

IDO1 and PDL1 are immune checkpoints with key roles in immune system regulation. Their relevance stems from their ability to suppress T-cell function. T-cells are vital to the body’s immune response ...

Rheumatologists and dermatologists highlight Saphnelo, Sotyktu, and litifilimab as leading candidates to address unmet needs in CLE patients, particularly those with systemic involvementEXTON, PA, ...